Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -19.50% |
| 2023 | 30.92% |
| 2022 | 124.43% |
| 2021 | 8.31% |
| 2020 | -4.71% |
| 2019 | 76.25% |
| 2018 | 13.45% |
| 2017 | 0.20% |
| 2016 | -53.02% |
| 2015 | -2.75% |